Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 16
2003 8
2004 15
2005 6
2006 4
2007 4
2008 13
2009 12
2010 22
2011 12
2012 20
2013 24
2014 36
2015 23
2016 24
2017 27
2018 26
2019 33
2020 30
2021 44
2022 44
2023 34
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

418 results

Results by year

Filters applied: . Clear all
Page 1
Tumor Immune Microenvironment during Epithelial-Mesenchymal Transition.
Taki M, Abiko K, Ukita M, Murakami R, Yamanoi K, Yamaguchi K, Hamanishi J, Baba T, Matsumura N, Mandai M. Taki M, et al. Among authors: yamaguchi k. Clin Cancer Res. 2021 Sep 1;27(17):4669-4679. doi: 10.1158/1078-0432.CCR-20-4459. Epub 2021 Apr 7. Clin Cancer Res. 2021. PMID: 33827891 Review.
CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer.
Ukita M, Hamanishi J, Yoshitomi H, Yamanoi K, Takamatsu S, Ueda A, Suzuki H, Hosoe Y, Furutake Y, Taki M, Abiko K, Yamaguchi K, Nakai H, Baba T, Matsumura N, Yoshizawa A, Ueno H, Mandai M. Ukita M, et al. Among authors: yamaguchi k. JCI Insight. 2022 Jun 22;7(12):e157215. doi: 10.1172/jci.insight.157215. JCI Insight. 2022. PMID: 35552285 Free PMC article.
A T-cell-engaging B7-H4/CD3-bispecific Fab-scFv Antibody Targets Human Breast Cancer.
Iizuka A, Nonomura C, Ashizawa T, Kondou R, Ohshima K, Sugino T, Mitsuya K, Hayashi N, Nakasu Y, Maruyama K, Yamaguchi K, Akiyama Y. Iizuka A, et al. Among authors: yamaguchi k. Clin Cancer Res. 2019 May 1;25(9):2925-2934. doi: 10.1158/1078-0432.CCR-17-3123. Epub 2019 Feb 8. Clin Cancer Res. 2019. PMID: 30737243
B7-H3 Suppresses Antitumor Immunity via the CCL2-CCR2-M2 Macrophage Axis and Contributes to Ovarian Cancer Progression.
Miyamoto T, Murakami R, Hamanishi J, Tanigaki K, Hosoe Y, Mise N, Takamatsu S, Mise Y, Ukita M, Taki M, Yamanoi K, Horikawa N, Abiko K, Yamaguchi K, Baba T, Matsumura N, Mandai M. Miyamoto T, et al. Among authors: yamaguchi k. Cancer Immunol Res. 2022 Jan;10(1):56-69. doi: 10.1158/2326-6066.CIR-21-0407. Epub 2021 Nov 19. Cancer Immunol Res. 2022. PMID: 34799346 Free PMC article.
The Humeral Implant in Shoulder Arthroplasty.
Keener JD, Chalmers PN, Yamaguchi K. Keener JD, et al. Among authors: yamaguchi k. J Am Acad Orthop Surg. 2017 Jun;25(6):427-438. doi: 10.5435/JAAOS-D-15-00682. J Am Acad Orthop Surg. 2017. PMID: 28459709 Review.
Molecular profiling of gastric neuroendocrine carcinomas.
Ikegame K, Hatakeyama K, Terashima M, Sugino T, Aizawa D, Furukawa K, Fujiya K, Tanizawa Y, Bando E, Yamaguchi K. Ikegame K, et al. Among authors: yamaguchi k. Eur J Surg Oncol. 2023 Sep;49(9):106987. doi: 10.1016/j.ejso.2023.106987. Epub 2023 Jul 13. Eur J Surg Oncol. 2023. PMID: 37463826
Ultrafast Dynamic Contrast-enhanced MRI of the Breast: How Is It Used?
Kataoka M, Honda M, Ohashi A, Yamaguchi K, Mori N, Goto M, Fujioka T, Mori M, Kato Y, Satake H, Iima M, Kubota K. Kataoka M, et al. Among authors: yamaguchi k. Magn Reson Med Sci. 2022 Mar 1;21(1):83-94. doi: 10.2463/mrms.rev.2021-0157. Epub 2022 Feb 25. Magn Reson Med Sci. 2022. PMID: 35228489 Free PMC article. Review.
418 results